Broad spectrum antiemetic effects of CP-122,721, a tachykinin NK1 receptor antagonist, in ferrets
- 3 June 1996
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 305 (1-3) , 181-185
- https://doi.org/10.1016/0014-2999(96)00216-6
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Neuroactive substances in the dorsal vagal complex of the medulla oblongata: nucleus of the tractus solitarius, area postrema, and dorsal motor nucleus of the vagusPublished by Elsevier ,2003
- Enantiospecific inhibition of emesis induced by nicotine in the house musk shrew (Suncus murinus) by the neurokinin1 (NK1) receptor antagonist CP-99,994Neuropharmacology, 1995
- The anti‐emetic effects of CP‐99,994 in the ferret and the dog: role of the NK1 receptorBritish Journal of Pharmacology, 1995
- Anti-emetic profile of a non-peptide neurokinin NK1 receptor antagonist, CP-99,994, in ferretsEuropean Journal of Pharmacology, 1993
- The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferretEuropean Journal of Pharmacology, 1993
- The neuropharmacology of loperamide-induced emesis in the ferret: The role of the area postrema, vagus, opiate and 5-HT3 receptorsNeuropharmacology, 1992
- The abdominal visceral innervation and the emetic reflex: pathways, pharmacology, and plasticityCanadian Journal of Physiology and Pharmacology, 1990
- The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694British Journal of Cancer, 1988
- Responses of neurons of canine area postrema to neurotransmitters and peptidesCellular and Molecular Neurobiology, 1983